Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Indoco Remedies Limited, is a listed public company incorporated on 23 August, 1947. It is classified as a public limited company and is located in Mumbai, Maharashtra. It's authorized share capital is INR 25.00 cr and the total paid-up capital is INR 18.44 cr.
Indoco Remedies Limited's operating revenue range is Over INR 500 cr for the financial year ending on 31 March, 2022. It's EBITDA has increased by 46.26% over the previous year. At the same time, it's book networth has increased by 17.61%.
Read more
This action will use 1 of your credits. Are you sure you want to go ahead?
** All rupee values in INR crores. Based on March 2022 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
State | Type | Address |
---|
Read more
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
---|---|---|---|---|---|
Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Networth | |||||
Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
---|---|---|---|---|---|
Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
---|---|---|---|---|---|
Sales + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Sales growth % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Expenses + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cost of goods | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Employee cost | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other costs | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other income | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Interest | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Depreciation | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Exceptional items | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Profit before tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Profit - disc. ops | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
---|---|---|---|---|---|
Solvency + | |||||
Total Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total Debt/Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total Assets/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Liquidity + | |||||
Current Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Quick Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Interest Coverage | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Performance | |||||
Gross Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Return + | |||||
Return on Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Pre-tax ROCE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Return on Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Pre-tax ROIC | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Efficiency + | |||||
Days Payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days Inventory | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days Receivable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Working Capital | |||||
Cash Conversion Cycle | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Working Capital Days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
HDFC Bank Limited
No. of Loans: 6
Total Amount : 215.0 cr
The Sarawat Co-operative Bank Limited
No. of Loans: 3
Total Amount : 57.0 cr
THE SARASWAT COOPERATIVE BANK
No. of Loans: 1
Total Amount : 50.0 cr
Saraswat Co-operative Bank Ltd
No. of Loans: 1
Total Amount : 30.0 cr
DBS BANK INDIA LIMITED
No. of Loans: 1
Total Amount : 15.0 cr
SARASWAT COOP BANK LIMITED
No. of Loans: 1
Total Amount : 15.0 cr
IDBI Bank Limited
No. of Loans: 1
Total Amount : 14.0 cr
State Bank of India
No. of Loans: 1
Total Amount : 13.7 cr
Kotak Mahindra Bank Limited
No. of Loans: 1
Total Amount : 10.0 cr
CitiBank N.A.
No. of Loans: 1
Total Amount : 10.0 cr
Standard Chartered Bank
No. of Loans: 1
Total Amount : 10.0 cr
Members Secretary Himachal Pradesh
No. of Loans: 1
Total Amount : 0.3 cr
Canara Bank
No. of Loans: 2
Total Amount : 0.1 cr
THE MAHRASHRTRA STATE FINANCIAL CORPORATION
No. of Loans: 1
Total Amount : 0.0 cr
Designation | Name | DIN/PAN | Tenure |
---|---|---|---|
Managing Director | Sundeep Vasant Bambolkar
Shareholder
|
00176613 | 21 years |
Managing Director | Aditi Milind Panandikar
Shareholder
|
00179113 | 21 years |
Whole-time Director | Suresh Govind Kare
Shareholder
|
00179220 | 61 years |
Director | Satish Madhav Shenoy | 00230711 | 1 years |
Director | Abhijit Yashawant Gore
Shareholder
|
00301688 | 4 years |
Director | Anand Madhusudan Nadkarni | 06881461 | 10 years |
Director | Vasudha Vasant Kamat | 07500096 | 5 years |
CFO | Pramod Ramchandra Ghorpade | <HIDDEN> | 3 years |
Director | Ajay Prasan Mulgaokar | 10457626 | 1 years |
Kmp | Ramanathan Hariharan | <HIDDEN> | 2 years |
Name | State / Country | Incorporation Year | Paidup Capital |
---|---|---|---|
Indoco Remedies Czech sro | C Z E C H Republic | - | - |
Indoco Remedies UK Limited* | United Kingdom | - | - |
XTEND INDUSTRIAL DESIGNERS AND ENGINEERS PRIVATE LIMITED | Maharashtra | 1995 | ₹ 2.0 Cr |
The incorporation date of INDOCO REMEDIES LIMITED is 23 August, 1947
The authorized share capital of INDOCO REMEDIES LIMITED is INR ₹ 25.0 Cr.
The paid-up capital of INDOCO REMEDIES LIMITED is INR ₹ 18.4 Cr.
The registered address of INDOCO REMEDIES LIMITED is INDOCO HOUSE 166 CST ROADVIDYANAGARI MARG KALINA SANTACRUZ EAST NA MUMBAI Maharashtra - 400098
The CIN number of INDOCO REMEDIES LIMITED is L85190MH1947PLC005913.